study question: What are the access, effectiveness and safety of assisted reproductive technology (ART) worldwide in 2006? summary answer: ART access, effectiveness and safety vary markedly among countries. Overall, there was an increase in the use of ICSI, single embryo transfer (SET) and frozen embryo transfer (FET). There was a decline in the multiple delivery rate (DR) and preterm birth rate.
Introduction
This is the 12th World Report on assisted reproductive technology (ART) and the seventh prepared by the International Committee Monitoring Assisted Reproductive Technologies (ICMART) de Mouzon et al., 2009; Nygren et al., 2011; Sullivan et al., 2013; Zegers-Hochschild et al., 2013) . Data were first collected on the number of ART cycles worldwide in 1989 by the International Working Group for Registers on Assisted Reproduction (IWGROAR) (Cohen et al., 1993; Lancaster, 1995, 1997; de Mouzon et al., 1998; Adamson et al., 2001) . In 2001, ICMART continued this activity. ICMART is a non-governmental organization (NGO) in official relations with the World Health Organization (WHO). The aim of this report is to provide global ART data for the Year 2006 for use in monitoring the access, effectiveness and safety of ART.
Materials and Methods

Data collection
The forms for data collection were developed by ICMART and sent to each country or regional ART register to be completed voluntarily. The 2009 ICMART-WHO revised glossary ) was used as a reference for terminology. This report covers ART-initiated treatment cycles between 1 January 2006 and the 31 December 2006 and is based on aggregated country data.
Data were supplied to the Uppsala Clinical Research (UCR) Center, Uppsala University, Uppsala, Sweden, where data validation was undertaken, a statistical plan was developed with the investigators, and a statistical report was prepared. The delay in reporting of data is a result of logistical difficulties regarding international data collection.
Data were provided directly from national ART registries or from regional registries. According to regions, data came either from individual clinics to the national register and then to the regional registry, or directly to the regional registry. Finally, in a few countries with no national or regional registers, data came directly from individual clinics. For this report data were received from a total of 56 countries belonging to seven regions. When a specific set of data was unavailable in a certain country, it was registered as not available (NA). The forms for data collection were designed to obtain information on the number of treatments and pregnancies for four reporting categories: (i) IVF, (ii) ICSI, (iii) gamete intra-Fallopian transfer and (iv) frozen embryo transfer (FET: IVF/ICSI) for initiated cycles, aspirations, transfers, pregnancies and deliveries. Data on aspirations, pregnancies and deliveries by woman's age category were also obtained. Data on the number of transferred embryos for fresh transfers and FETs were obtained.
The forms include data on gestational age by treatment and multiple deliveries, neonatal outcome (live birth, stillbirth and neonatal death), preimplantation genetic diagnosis, oocyte donation (OD), treatment complications and congenital anomalies. The forms also collect information on intrauterine insemination from husband (IUI-H), and donors (IUI-D) by women's age, in vitro maturation (IVM), surrogacy and multifetal reduction.
Data management
Country and regional data were provided to ICMART. Data management and analysis were undertaken by UCR Center Sweden.
SAS software (version 9.3) was used for data management and to create tables. Graphs were obtained using R (version 2.14.1).
Imputation of missing data
In countries with missing data on the number of initiated cycles, aspirations, pregnancies or deliveries, estimations were made according to certain premises, as published previously .
Results
The results are presented in Tables I-IV and Figs 1-3. Tables SI -SX and Figs S1-S9 are available as Supplementary data online.
Access
Data were received from 2352 (84.4%) of known ART clinics in 56 countries. There are 15 fewer clinics and 3 more countries than in 2005. At the regional level Europe had the largest number of clinics providing data (n ¼ 999, 42% of total) followed by Asia (n ¼ 771, 33%). At a country level, Japan followed by the USA had the highest number of participating clinics (Supplementary data, Table SI ). Out of 56 countries included in this report, 31 (55.4%) received data from 100% of the clinics in that country. In countries where the sum of singleton, twins and triplets was less than the total number of deliveries, the number of unknown babies and lost-to-follow-up deliveries were estimated by applying distribution of observed deliveries in which this was known. g Initiated cycles overall countries estimation.
Effectiveness
Step 1: Reported cycles for countries reporting them, or estimation by applying their cancellation rate to the aspiration (Asp) numbers for the countries not reporting them.
Step 2 Table SIVb ). Supplementary data, Figure S4 illustrates results according to age group.
Safety
The proportion of single embryo transfers (SETs) increased to 20.7% from 16.4% in 2004 and 17.5% in 2005, with the highest rates in Sweden (69.9%), New Zealand (61.4%), Finland (54.7%) and Australia (53.3%) (Table IV) . This increase in the practice of SETs was reflected in the decrease of twin deliveries from 25.1% in 2004 and 23.6% in 2005 to 22.2% in 2006. Moreover, the proportion of triplet deliveries continued to decrease from 2.0% in 2003, to 1.8% in 2004 and 1.5% in each of 2005 and 2006. However, multiple pregnancy rates varied markedly among countries (Table IV , Supplementary data, Fig. S5 ); considering only countries that reported .2000 cycles, the percentage of twin deliveries was .25% in six countries (Greece, Egypt, USA, Canada, Ukraine and South Korea) and ,10% in two countries (Sweden and New Zealand). Triplet and high-order multiple deliveries varied from .3% in four countries (India, Argentina, Brazil and Mexico) to ,0.3% in seven countries (Finland, Sweden, Denmark, Belgium, Norway, New Zealand and Slovenia). Figure 1 and Supplementary data, Fig. S6 Table SV ). The mean number of embryos per transfer in fresh IVF/ICSI was 2.22 with great variations among countries (Supplementary data, Figs S7 and  S8 ). However, it was not correlated with the overall DRs (Fig. 2, Supplementary data, Fig. S9 ), (r ¼ 0.10, P ¼ 0.50). There is a trend towards a steady decrease in the mean number of embryos per transfer from 2.37 in 2003, to 2.35 in 2004, to 2.29 in 2005, to 2.22 in 2006. In fresh non-donor cycles the overall DRs per transfer were 27.3 and 27.6% when three or four embryos were transferred, respectively. This was lower than the 29.4% DR per transfer when two embryos were transferred (Supplementary data, Continued countries provided only the number of IUI cycles without the numbers of pregnancies or deliveries.
Discussion
Monitoring ART practice, outcomes and complications at an international level is essential to quantifying the access to ART services, determining effectiveness of infertility treatment services, identifying safety issues in ART, and providing an evidence base for use in advocacy, education and policy development on ART. The annual collection of ICMART data is essential to developing comprehensive international statistics on ART. This ICMART report covers an estimated two-thirds of the world's ART activities in 2006.
Access
ART access, like other medical services, varies greatly among countries according to economic status, cultural characteristics, government policy, regulations, societal financial support, the number of service providers and other known and unknown factors (Adamson, 2009) . In some regions (Latin America) ART availability was 77 cycles per million population, while in other regions, such as Australia and New Zealand, it was 1979 cycles per million populations.
For proper evaluation of ART availability we need to measure infertility prevalence. A review of the literature on prevalence studies measuring infertility highlights a lack in consistency of determining prevalence because of use of different definitions of duration of infertility (Gurunath et al., 2011) . To measure infertility on a population level, it is best to use the demographic definition of infertility (Mascarenhas et al., 2012) . Analysis of 53 surveys representing 26 countries shows the age-standardized prevalence of primary infertility ranging from 0.6 to 3.4% and of secondary infertility from 8.7 to 32.6% (Mascarenhas et al., 2012) . In another study examining 25 population surveys, the estimated overall median prevalence of infertility was 9% (Boivin et al., 2007) . In 2006 the world population was 6.7 billion (United Nations, 2007) . Based on the above two studies we can estimate that 72.4 million women were infertile in 2006. If we assume only 20% of this infertile population will ultimately need ART, this means an estimated 15 million ART cycles were needed worldwide in the Year 2006. The ICMART report estimated 1 million initiated ART cycles were undertaken in 2006. If we consider that the report covered about two-thirds of the world ART activity this suggests that 1.5 million ART cycles were likely undertaken in 2006. This is a significant mismatch between the need and availability of ART with an estimated 15 million ART cycles needed and only 
Effectiveness
A reasonable approach to evaluate effectiveness of ART treatment is to combine the results of the fresh cycle transfers plus the FETs with embryos from that cycle to obtain cumulative PRs and DRs. It is not possible to provide confident cumulative data on a worldwide basis since most countries provide summary reports rather than individualized case-by-case reports. In spite of this, cumulative data can be extrapolated as described previously . In 2006, the cumulative DR increased to 25.2% compared with 24.3% in 2004 and 23.9% in 2005. The wide use of FETs and the optimization of cryopreservation techniques will ultimately increase the gap between the DRs in the initial fresh cycle transfer and the cumulative DRs when all embryos from a given aspiration cycle are transferred. This is already evident in some countries, such as Australia, New Zealand, Finland, Switzerland and Iceland which have reported .10% increase in the cumulative DRs compared with fresh cycles DRs. There is a wide variation among countries in the DRs for fresh cycles and FETs. The highest cumulative DR (40.3%) was reported by the USA, even though 19.4% of the women were ≥40 years old. It is important to note that the DR per aspiration was not correlated with the mean number of embryos transferred (Fig. 2) . Spontaneous miscarriage occurred more frequently after FETs when compared with fresh cycles, which may be a result of the difference in women's age as well as other unknown factors. Despite this finding, some individual literature reports have shown improved outcomes following FET compared with fresh transfer and so the issue of reproductive outcome of fresh compared with frozen transfer needs further assessment before firm conclusions can be drawn.
Utilization of ICSI continued to rise markedly from 47.6% in 2000 to 66.0% in 2006. The preference of ICSI over conventional IVF as the method of fertilization was seen across all regions, with major variations among countries, reaching 96% in the Middle East when compared with 56% in Asia. The reasons for this increase are not fully understood. Generally, it denotes either an increase in the medical indications for ICSI and/or clinical preference of ICSI as an efficient method of fertilization (Aboulghar et al., 1996) . Consequently, it might be the first choice for couples with no medical coverage. The perinatal risks associated with the use of ICSI or IVF have been the focus of many studies. A recent controlled national cohort study demonstrated that children born after ICSI using surgically retrieved sperm have a similar neonatal outcome, including total birth defect rates, as children born after ICSI and IVF using ejaculated sperm (Fedder et al., 2013) . However, another large study found an increase in birth defects with ICSI but not with IVF (Davies et al., 2012) . Therefore, further surveillance and research of this complex issue is warranted.
Safety
One of the main concerns in ART is the high multiple DR. The triplet and higher order DRs decreased to 1.5% in 2006 and 2005 compared with 2.0% in 2003, and 1.8% in 2004. However, this triplet rate remains significantly higher than natural conception (1 in 6000-8000) (Guttmacher, 1953) . Twin DRs decreased from 25.1% in 2004 to 23.6% in 2005 and 22.2% in 2006, which is still very high when compared with natural conception (1.6%) (ESHRE Capri Workshop, 2000) . In the UK, the multiple birth rates after ART in 2006 were 235 twins and 3 triplets per thousand, which is 15 times higher than the rates in natural conception (10.4 and 15.3 per thousand in the Years 1970 and 2006, respectively) (Statistical Bulletin, 2012) .
The high multiple DRs after ART is iatrogenic and can be, to a great extent, controlled through limiting the number of embryos per transfer. The mean number of embryos per transfer in 2006 was 2.22 compared with 2.35 in 2004 and 2.29 in 2005. However, it should be noted that there are great variations among countries in the average number of embryos per transfer. In fresh IVF/ICSI the average number of embryos per transfer was ,1.5 embryos in three countries (Sweden, New Zealand and Australia) and was .3 embryos in two countries (South Korea, Albania). It should also be noted that the decrease in the triplet DRs in some countries is a reflection of multifetal reduction, rather than a decrease in the average number of embryos per transfer (Mansour et al., 1999) . Even though multifetal reduction is a relatively effective technology to avoid the consequences of multiple births, this practice raises significant professional and ethical issues.
The proportion of SETs increased from 16.4% in 2004 to 17.5% in 2005 and 20.7% in 2006, with marked variations among countries. The leading four countries practicing SET were Sweden (69.9%), New Zealand (61.4%), Finland (54.7%) and Australia (53.3%). The ultimate goal is to optimize IVF/ICSI laboratory techniques as well as ovarian stimulation, embryo assessment and embryo transfer techniques in order to be able to transfer one high-quality viable embryo in the appropriately selected patients.
The decrease in multiple DRs was directly reflected in the preterm DRs that declined markedly compared with previous years (33.7% in 2004, 26.6% in 2005 to 22.1% in 2006) .
The frequency of OHSS dropped from 1.2% in 2004 to 1.1% in 2005, to 0.6% in 2006. It is important for ART centers to utilize protocols that decrease as much as possible the incidence of OHSS. Another main concern in ART practice is the incidence of congenital malformations, which are usually incompletely reported and, in any event, do not have standardized definitions and reporting even in many developed countries. At the international level this type of detail currently can only be reported in generalities that have very limited utility . Record linkage at a country level with perinatal registers is a better option to compare neonatal outcomes of ART babies with natural conception .
Limitations
This report covers about two-thirds of the world ART activity, which means that approximately one-third of the ART data have not been reported and therefore cannot be collected or analyzed by ICMART.
ICMART continues to work at an international level to obtain data from countries that are beginning to collect data including China, Indonesia, Pakistan, the Philippines, Bangladesh and sub-Saharan Africa. Additionally, some countries provide data that are incomplete. Furthermore, the quality of data varies among individual countries and is dependent on the local regulatory authority's policy and ability to monitor ART clinics.
To standardize terminology and improve data reporting, ICMART has published original and revised glossaries in collaboration with WHO (ICMART Glossary, 2002; Zegers-Hochschild et al., 2006 , 2009 and has recently published a 'toolkit' to support data collection practices for countries setting up registries to monitor ART (www.icmartivf. org/toolbox/toolbox-main.html). Moreover ICMART, as an NGO in official relations with WHO, has collaboratively organized workshops in different regions and countries to help them establish their own ART registries.
Trends
